For solid tumors and hematological malignancies, CAR-NK cell treatment is a novel kind of cancer immunotherapy. CAR-NK cells work by killing cancer cells in a CAR-dependent way. CAR-NK cells and ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

The early successors in cell therapy have mostly been CAR-T therapies ... Promising work is being done with natural killer, or NK cells, a different kind of immune system cell that could work ...

GloboCare announced that it has been granted the patent right and Certificate of Invention for its CAR-T and CAR-NK cell ...

and efficacy of CAR-T and CAR-Natural Killer (NK) cells. Key features of the patent include: Bispecific Anti-CD19xCD22 CAR: A novel design that targets both CD19 and CD22 antigens for purposes of ...